Latebreakers: Combo diabetes drug gets FDA nod

The FDA has approved the combination of sitagliptin (Januvia, Merck) and metformin for the treatment of Type 2 diabetes.

Related Videos
Dr. Charles Lee
© 2023 MJH Life Sciences

All rights reserved.